Skip to main content

A Tribute to Paul Greengard (1925-2019)

  • 1st Edition, Volume 90 - March 2, 2021
  • Latest edition
  • Editor: Stevin H. Zorn
  • Language: English

A Tribute to Paul Greengard, Volume 90, the latest release in the Advances in Pharmacology series presents a variety of chapters from the best authors in the field, with this rel… Read more

Data Mining & ML

Unlock the cutting edge

Up to 20% on trusted resources. Build expertise with data mining, ML methods.

Description

A Tribute to Paul Greengard, Volume 90, the latest release in the Advances in Pharmacology series presents a variety of chapters from the best authors in the field, with this release presenting a tribute to Paul Greengard.

Key features

  • Includes the authority and expertise of leading contributors in pharmacology
  • Presents the latest release in the Advances in Pharmacology series

Readership

Investigators in neuroscience, pharmacology, neurology, psychiatry, medicine

Table of contents

1. Paul Greengard: A persistent desire to comprehend the brain, and also to fix it
Marc Flajolet, Thu Lan N-Guyen, Vijay Kumar Siripuram and Yashoda Krishna Sunkari

2. Giving names to the actors of synaptic transmission: The long journey from synaptic vesicles to neural plasticity
Fabio Benfenati, Martin Bähler and Flavia Valtorta

3. cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases
Kyle R. Christensen and Angus C. Nairn

4. DARPP-32 40 years later
Jean-Antoine Girault and Angus C. Nairn

5. Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction
Angela M. Lee and Marina R. Picciotto

6. Modulation of dendritic spines by protein phosphatase-1
Jimcy Platholi and Hugh C. Hemmings Jr

7. Deciphering cell-type specific signal transduction in the brain: Challenges and promises
Jean-Pierre Roussarie and Patricia Rodriguez-Rodriguez

8. Drug-activated cells: From immediate early genes to neuronal ensembles in addiction
Marine Salery, Arthur Godino and Eric J. Nestler

9. NAPE-specific phospholipase D regulates LRRK2 association with neuronal membranes
Francesca Palese, Silvia Pontis, Natalia Realini and Daniele Piomelli

10. Amyloidogenic and anti-amyloidogenic properties of presenilin 1
Victor Bustos, Maria Pulina and Jose Ledo

11. A review of the pharmacology and clinical profile of lumateperone for the treatment of schizophrenia
Gretchen L Snyder, Kimberly E Vanover, Robert E Davis, Peng Li, Allen Fienberg and Sharon Mates

12. Uniting homeostatic plasticity and exosome biology: A revision of the conceptual framework for drug discovery in neurodegenerative diseases?
James K.T. Wang

Product details

  • Edition: 1
  • Latest edition
  • Volume: 90
  • Published: March 2, 2021
  • Language: English

About the editor

SZ

Stevin H. Zorn

Stevin Zorn is President and CEO at MindImmune Therapeutics, Inc., Kingston, RI, USA
Affiliations and expertise
President and CEO, MindImmune Therapeutics, Inc., Kingston, RI, USA

View book on ScienceDirect

Read A Tribute to Paul Greengard (1925-2019) on ScienceDirect